Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio
All News
Headline News
Press Releases
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
News headline image
Cognition Therapeutics Schedules a Type C Meeting with FDA to Align on Endpoints for Phase 3 Trial of Zervimesine (CT1812) in DLB
From Cognition Therapeutics, Inc.
Via GlobeNewswire
Tickers CGTX
News headline image
Medicus Pharma Submits Optimized Teverelix® Registrational Protocol to FDA to Create Partner Ready Program in Advanced Prostate Cancer
From Medicus Pharma Ltd
Via GlobeNewswire
Tickers MDCX
News headline image
Jeffrey Hecht Joins FTI Consulting to Lead Private Equity Tax and Advisory Services
From FTI Consulting, Inc.
Via GlobeNewswire
Tickers FCN
News headline image
Cellectar Biosciences to Present Compelling Efficacy Data from Phase 2 CLOVER WaM Subset Analysis of Iopofosine I 131 in Patients Refractory/Resistant to BTK Inhibitor Therapy at International Workshop for Waldenström Macroglobulinemia
From Cellectar Biosciences, Inc.
Via GlobeNewswire
Tickers CLRB
News headline image
HdL Companies Recognized for Employee Ownership Excellence Amid Continued Growth
From HdL Companies
Via GlobeNewswire
News headline image
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington’s Disease Showing Continued Slowing of Disease Progression
From uniQure Inc.
Via GlobeNewswire
Tickers QURE
News headline image
Immix Biopharma Announces Pricing of $125 Million Underwritten Offering of Common Stock
From Immix Biopharma, Inc.
Via GlobeNewswire
Tickers IMMX
News headline image
Boehringer Ingelheim investments into sustainability-related programs and health partnerships to reach EUR 500 million
From Boehringer Ingelheim
Via GlobeNewswire
News headline image
Ocugen to Participate in Upcoming October Investor and Industry Conferences
From Ocugen
Via GlobeNewswire
Tickers OCGN
News headline image
PolarityBio’s Phase 3 COVER DFUS II Trial Selected for First-to-Podium Presentation at SAWC Fall 2026
From PolarityBio
Via GlobeNewswire
News headline image
Invivyd Announces Positive Topline Results from LIBERTY Phase 3 Study Demonstrating VYD2311 Safety and Tolerability Superior to mRNA-based COVID-19 Vaccine; Announces Regulatory Submission Plans for VYD2311
From Invivyd, Inc.
Via GlobeNewswire
Tickers IVVD
News headline image
EliseAI Raises $350 Million at $4 Billion Valuation to Bring AI Deeper Into Housing and Healthcare Operations
From EliseAI
Via GlobeNewswire
News headline image
ProductLife Group completes its transformation into a single, unified group with an end-to-end set of human and digital capabilities across life sciences
From ProductLife Group (PLG)
Via GlobeNewswire
News headline image
Alpha Compute Update on Operating Oil and Gas Assets Due Diligence in Pennsylvania, Securing 300+ Acres Across the Marcellus and Utica Shales
From Alpha Compute Corp.
Via GlobeNewswire
Tickers ALP
News headline image
Aurora Mobile's GPTBots.ai Helps Ruko Cut Support Ticket Response Time from Two Hours to Under 10 Minutes
From Aurora Mobile Limited
Via GlobeNewswire
Tickers JG
News headline image
Northland Power Brings Alberta’s Largest Battery Storage Facility Online Ahead of Schedule and Under Budget
From Northland Power Inc.
Via GlobeNewswire
Tickers TSX:NPI
News headline image
Iovance Biotherapeutics Raises Full Year 2026 Revenue Guidance to $410 to $420 Million
From Iovance Biotherapeutics, Inc.
Via GlobeNewswire
Tickers IOVA
News headline image
Immix Biopharma Announces 89% Complete Response Rate at Interim Update Across All NEXICART-2 Patients, with MRD-Negativity Indicating Potential to Reach up to 98% Complete Response Rate, Supporting Potential Best-in-Class Therapy for Relapsed/Refractory
From Immix Biopharma, Inc.
Via GlobeNewswire
Tickers IMMX
News headline image
First Quantum Provides Notice of Third Quarter 2026 Results
From First Quantum Minerals Ltd.
Via GlobeNewswire
Tickers TSX:FM
News headline image
Barrick to Present at Mining Forum Americas
From Barrick Mining Corporation
Via GlobeNewswire
Tickers B TSX:ABX
News headline image
Apriem Advisors Earns Three National and Regional Recognitions in 2026
From Apriem Advisors
Via GlobeNewswire
News headline image
Amplify ETFs Declares September Income Distributions for its Income ETFs
From Amplify ETFs
Via GlobeNewswire
Tickers BAGY BITY EHY ETTY HCOW HYGM
News headline image
Aquestive Therapeutics Strengthens Board of Directors with Appointment of Richard Daly
From Aquestive Therapeutics, Inc.
Via GlobeNewswire
Tickers AQST
News headline image
PyroGenesis Completes Acquisition of 50% Ownership Interest in HPQ Silica Polvere Inc., Rights-Holder of the Fumed Silica Reactor Technology
From PyroGenesis Inc.
Via GlobeNewswire
Tickers PYRGF TSX:PYR
News headline image
CDT Highlights Sarborg’s Expanding Quantum Computing IP Portfolio and Application to Drug Discovery
From CDT Equity Inc.
Via GlobeNewswire
Tickers CDT
News headline image
OKYO Pharma Presents and Participates at Upcoming Ophthalmic Scientific Conferences
From OKYO Pharma LTD
Via GlobeNewswire
Tickers OKYO
News headline image
Luckin Coffee Announces Appointment of New Director
From Luckin Coffee Inc.
Via GlobeNewswire
Tickers LKNCY
News headline image
EVgo Announces Next-Generation Charging System Capable of 750kW
From EVgo Services LLC
Via GlobeNewswire
Tickers EVGO
News headline image
GDEV announces preliminary results of previously announced self tender offer to purchase for cash up to $20,000,000 in value of its ordinary shares (or up to 1,813,236 Ordinary Shares) at a purchase price of $11.03 per ordinary share
From GDEV Inc.
Via GlobeNewswire
Tickers GDEV
News headline image
Cascade Prodrug Inc. Appoints Kenneth Mandell, M.D., Ph.D. to Board of Directors
From Cascade Prodrug Inc.
Via GlobeNewswire
< Previous 1 2
...
29 30 31 32 33 34 35 36 37
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.